- ICH GCP
- Registro degli studi clinici negli Stati Uniti
- Sperimentazione clinica NCT07841886
XRAIconnect Image Guidance Software for ERCP Procedures
XRAIconnect ERCP - A Single-center Feasibility Study of XRAIconnect Image Guidance Software for ERCP Procedures
The purpose of this research is to establish the usability, feasibility and utility of using XRAIconnect, a software medical device for operative image guidance for endoscopic retrograde cholangiopancreatography (ERCP) procedures. There will be prospective enrollment of up to 50 adult patients (18 years or older) undergoing elective ERCP procedures to evaluate the device clinically. Participants' pre-operative magnetic resonance cholangiopancreatography (MRCP) imaging data will be used to create digital, 3D reconstructions of the biliary and pancreatic ducts and surrounding organs/pathology. These 3D models will be aligned with live, intra-operative 2D X-ray (fluoroscopy) videos/images during ERCP in a process known as registration. This allows operators to view anatomical structures in 3D, with (stereoscopically) or without the use of an Augmented Reality HMD (Apple Vision Pro). To perform a registration to align 3D models to the intra-operative 2D images, natural anatomical landmarks that can be consistently identified on all images act as surrogate fiducial markers. The study aims to demonstrate that XRAIconnect can be used successfully during ERCP procedures, producing 3D models of sufficient accuracy.
Panoramica dello studio
Stato
Intervento / Trattamento
Tipo di studio
Iscrizione (Stimato)
Fase
- Non applicabile
Contatti e Sedi
Contatto studio
- Nome: Tamas Gonda, MD
- Numero di telefono: 646-501-2465
- Email: Tamas.gonda@nyulangone.org
Luoghi di studio
-
-
New York
-
New York, New York, Stati Uniti, 10016
- NYU Langone Health
-
-
Criteri di partecipazione
Criteri di ammissibilità
Età idonea allo studio
Accetta volontari sani
Sessi ammissibili allo studio
Descrizione
Inclusion Criteria:
-
Scheduled for an ERCP at NYU Langone Health (NYULH);
-
ERCP type:
- First time ERCP for any indication; OR
- ERCP (first-time or repeat) specifically for intrahepatic interventions, including placement of intrahepatic stent, access to intrahepatic stones, and access to intrahepatic strictures;
-
Aged 18 years or over;
-
Able to provide written consent to participate in the study (taken either in person during pre-ERCP hospital visit or by email via SendSafe);
-
Have pre-operative MRCP imaging data available to transfer to Medical iSight Corporation with sufficient time available for data processing using the medical device (XRAIconnect software) prior to use during the ERCP.
Exclusion Criteria:
- Preprocedural or intraprocedural imaging of insufficient quality;
- Pregnant or breastfeeding.
Piano di studio
Come è strutturato lo studio?
Dettagli di progettazione
- Scopo principale: Fattibilità del dispositivo
- Assegnazione: N / A
- Modello interventistico: Assegnazione di gruppo singolo
- Mascheramento: Nessuno (etichetta aperta)
Armi e interventi
Gruppo di partecipanti / Arm |
Intervento / Trattamento |
|---|---|
|
Sperimentale: ERCP Cases
Patients scheduled for an ERCP procedure will undergo pre-operative MRCP imaging scans (MRI scans) which will be reconstructed into digital, 3D models of the biliary and pancreatic ducts and surrounding organs/pathology. At the ERCP visit and using XRAIconnect software, NYULH ERCP operators will align these models with live, intra-operative 2D X-ray (fluoroscopy) videos/images (registration), allowing operators to view anatomical structures in 3D, with (stereoscopically) or without the use of an extended reality head-mounted display. The accuracy of XRAIconnect in terms of mean fiducial registration error and mean multiplanar triangulation error will be measured. |
Medical device software that generates three-dimensional (3D) geometric models from pre-operative imaging, and is capable of aligning them to live 2D fluoroscopic imaging during interventions, to provide enhanced navigational cues and a native 3D understanding of the spatial relationships between instrumentation and patient anatomy. In the context of ERCP, XRAIconnect uses data from pre-operative MRCP data to generate 3D models of the hepatobiliary system and surrounding structures which can be aligned with live, intra-operative 2D X-ray (fluoroscopy) videos/images during ERCP in a process known as registration. |
Cosa sta misurando lo studio?
Misure di risultato primarie
Misura del risultato |
Misura Descrizione |
Lasso di tempo |
|---|---|---|
|
Mean fiducial registration error
Lasso di tempo: Approximately Week 8 (Day of Procedure)
|
Mean fiducial registration error is a measure of goodness of fit of the registration; measured in mm. |
Approximately Week 8 (Day of Procedure)
|
|
Mean multiplanar triangulation error
Lasso di tempo: Approximately Week 8 (Day of Procedure)
|
Mean multiplanar triangulation error is the error due to small inconsistencies in registration across the imaging planes which may cause the resulting 3D rays cast not to intersect at a single, consistent point in space, leading to a slight mismatch between the 2D and 3D correspondences; measured in mm. |
Approximately Week 8 (Day of Procedure)
|
Misure di risultato secondarie
Misura del risultato |
Lasso di tempo |
|---|---|
|
Fluoroscopy time
Lasso di tempo: Approximately Week 8 (Day of Procedure)
|
Approximately Week 8 (Day of Procedure)
|
|
Total procedure time
Lasso di tempo: Approximately Week 8 (Day of Procedure)
|
Approximately Week 8 (Day of Procedure)
|
|
Number of cannulation attempts
Lasso di tempo: Approximately Week 8 (Day of Procedure)
|
Approximately Week 8 (Day of Procedure)
|
|
Number of wires used
Lasso di tempo: Approximately Week 8 (Day of Procedure)
|
Approximately Week 8 (Day of Procedure)
|
|
Need for advanced cannulation techniques
Lasso di tempo: Approximately Week 8 (Day of Procedure)
|
Approximately Week 8 (Day of Procedure)
|
|
Post procedure complications within 24 hours
Lasso di tempo: within 24 hours
|
within 24 hours
|
Collaboratori e investigatori
Sponsor
Investigatori
- Investigatore principale: Tamas Gonda, MD, NYU Langone Health
Studiare le date dei record
Studia le date principali
Inizio studio (Stimato)
Completamento primario (Stimato)
Completamento dello studio (Stimato)
Date di iscrizione allo studio
Primo inviato
Primo inviato che soddisfa i criteri di controllo qualità
Primo Inserito (Effettivo)
Aggiornamenti dei record di studio
Ultimo aggiornamento pubblicato (Effettivo)
Ultimo aggiornamento inviato che soddisfa i criteri QC
Ultimo verificato
Maggiori informazioni
Termini relativi a questo studio
Parole chiave
Altri numeri di identificazione dello studio
- 26-00478
Piano per i dati dei singoli partecipanti (IPD)
Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?
Descrizione del piano IPD
Data will be specific to proprietary algorithm being studied in this trial and not relevant to outside researchers.
Informazioni su farmaci e dispositivi, documenti di studio
Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti
Studia un dispositivo regolamentato dalla FDA degli Stati Uniti
prodotto fabbricato ed esportato dagli Stati Uniti
Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .